Abstract
Post-mortem specimens from the Stanley Foundation Neuropathology Consortium, which contains matched samples from patients with schizophrenia, bipolar disorder, non-psychotic depression and normal controls (n = 15 per group), have been distributed to many research groups around the world. This paper provides a summary of abnormal markers found in prefrontal cortical areas from this collection between 1997 and 2001. With parametric analyses of variance of 102 separate data sets, 14 markers were abnormal in at least one disease. The markers pertained to a variety of neural systems and processes including neuronal plasticity, neurotransmission, signal transduction, inhibitory interneuron function and glial cells. The data sets were also examined using the non-parametric Classification and Regression Tree (CRT) technique for the four diagnostic groups and in pair-wise combinations. In contrast to the results obtained with analyses of variance, the CRT method identified a smaller set of nine markers that contributed maximally to the diagnostic classifications. Three of the nine markers observed with CRT overlapped with the ANOVA results. Six of the nine markers observed with the CRT technique pertained to aspects of glutamatergic, GABA-ergic, and dopaminergic neurotransmission.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
We are sorry, but there is no personal subscription option available for your country.
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Torrey EF Webster M Knable M Johnston N Yolken RH The Stanley Foundation Brain Collection and Neuropathology Consortium Schizophr Res 2000 44 151 155
Knable MB Torrey EF Webster MJ Bartko JJ Multivariate analysis of prefrontal cortical data from the Stanley Foundation Neuropathology Consortium Brain Res Bull 2001 55 651 659
Knable MB Barci BM Webster MJ Torrey EF Summary of prefrontal molecular abnormalities in the Stanley Foundation Neuropathology Consortium. In: Agam G, Belmaker RH, Everall I (eds) The Post-Mortem Brain in Psychiatric Research Kluwer Academic Publishers: Boston 2002 105 137
Broderik JP Lu M Kothari R Levine SR Lyden PD et alFinding the most powerful measures of the effectiveness of tissue plasminogen activator in the NINDS tPA stroke trial Stroke 2000 31 2335 2341
Harbeck N Alt U Berger U Kates R Kruger A Thomssen C et alLong-term follow-up confirms prognostic impact of PAI-1 and cathepsin D and L in primary breast cancer Int J Biol Markers 2000 15 79 83
Breiman L Friedman JH Olshen R Classification and Regression Trees CRC Press: Boca Raton, FL 1993
Cohen J Statistical Power Analysis for the Behavioral Sciences. 2nd edn Lawrence Erlbaum: Hillsdale, NJ 1998p42
Akbarian S Kim JJ Potkin SG Hagman JO Tafazzoli A Bunney WE et alGene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenia Arch Gen Psychiatry 1995 52 258 266
Volk DW Austin MC Pierri JN Sampson AR Lewis DA Decreased glutamic acid decarboxylase 67 messenger RNA expression in a subset of prefrontal cortical gamma-amino butyric acid neurons in subjects with schizophrenia Arch Gen Psychiatry 2000 57 237 245
Guidotti A Auta J Davis JM Gervini VD Dwivedi Y Grayson DR et alDecrease in reelin and glutamic acid decarboxylase 67 (GAD67) expression in schizophrenia and bipolar disorder Arch Gen Psychiatry 2000 57 1061 1069
Sakai K Gao XM Hashimoto T Tamminga CA Traditional and new antipsychotic drugs differentially alter neurotransmission markers in basal ganglia-thalamocortical neural pathways Synapse 2001 39 152 160
Webster MJ Knable MB O'Grady JO Orthmann J Shannon-Weickert C Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders Mol Psychiatry(in press)
Dingledine R Borges K Bowie D Traynelis SF Glutamate receptor ion channels Pharmacol Rev 1999 51 7 62
Myers SJ Dingledine R Borges K Genetic regulation of glutamate receptor ion channels Annu Rev Pharmacol Toxicol 1999 39 221 241
Conti F Weinberg RJ Shaping excitation at glutamatergic synapses TINS 1999 22 451 458
Akbarian S Sucher NJ Bradley D Tafazzoli A Trinh D Hetrick WP et alSelective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics J Neurosci 1996 16 19 30
Riva MA Tascedda F Lovati E Racagni G Regulation of NMDA receptor subunit messenger RNA levels in the rat brain following acute and chronic exposure to antipsychotic drugs Mol Brain Res 1997 50 136 142
Tascedda F Lovati E Blom JMC Muzzioli P Brunello N Racagni G et alRegulation of ionotropic glutamate receptors in the rat brain in response to the atypical antipsychotic Seroquel Neuropsychopharmacology 1999 21 211 217
Boyer PA Skonick P Fossom LH Chronic administration of imipramine and citalopram alters the expression of NMDA receptor subunit mRNAs in mouse brain. A quantitative in situ hybridization study J Mol Neurosci 1998 10 219 233
Petrie RX Reid IC Stewart CA The N-methyl-D-aspartate receptor, synaptic plasticity, and depressive disorder. A critical review Pharmacol Ther 2000 87 11 25
Healy DJ Meador-Woodruff JH Clozapine and haloperidol differentially affect AMPA and kainate receptor subunit mRNA levels in rat cortex and striatum Mol Brain Res 1997 47 331 338
Snyder SH Ferris CD Novel neurotransmitters and the neuropsychiatric relevance Am J Psychiatry 2000 157 1738 1751
Ferrer I Alpha-synucleinopathies Neurologia 2001 16 163 170
Rosengren E Linder-Eliasson E Carlsson A Detection of 5-S-cysteinyldopamine in human brain J Neural Transm 1985 63 247 253
Carlsson A Waters N Hansson LO Neurotransmitter aberrations in schizophrenia: new findingsIn: Fog R, Gerlach J, Hemmingsen R (eds)SchizophreniaAlfred Benzon Symposium: Copenhagen1995pp332 340
Hansson LO Waters N Winblad B Gottfries C-G Carlsson A Evidence for biochemical heterogeneity in schizophrenia: a multi-variate study of monoaminergic indices in human post-mortem brain tissue J Neural Transm [Gen Sect] 1998 98 217 235
Kozlovsky N Belmaker RH Agam G Low GSK-3β immunoreactivity in postmortem frontal cortex of schizophrenic patients Am J Psychiatry 2000 157 831 833
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Knable, M., Barci, B., Bartko, J. et al. Molecular abnormalities in the major psychiatric illnesses: Classification and Regression Tree (CRT) analysis of post-mortem prefrontal markers. Mol Psychiatry 7, 392–404 (2002). https://doi.org/10.1038/sj.mp.4001034
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.mp.4001034